High prevalence of respiratory symptoms during air travel in patients with COPD

Respiratory Medicine

Volumn 105, Issue 1, 2011, Pages 50-56

  Edvardsen, Anne ^a   Akerø, Aina ^b   Hardie, Jon A ^c   Ryg, Morten ^a   Eagan, Tomas M L ^c   Skjønsberg, Ole H ^b   Bakke, Per S ^c  

^a Glittreklinikken AS   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Air travel; Chronic obstructive pulmonary disease; COPD; Dyspnea; Hypoxia

Indexed keywords

ADULT; ARTICLE; AVIATION; BLOOD GAS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DYSPNEA; EXERCISE; FEMALE; GROUPS BY AGE; HUMAN; HYPOXIA; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RECORDING; SEX DIFFERENCE; SMOKING;

AEROSPACE MEDICINE; ANOXIA; CROSS-SECTIONAL STUDIES; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; NORWAY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; RESPIRATORY FUNCTION TESTS; RISK FACTORS; TRAVEL;

EID: 78649973194     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2010.10.006     Document Type: Article

References (28)

1. D. Silverman, and M. Gendreau Medical issues associated with commercial flights Lancet 373 9680 2009 2067 2077
2. Managing passengers with respiratory disease planning air travel: British Thoracic Society recommendations Thorax 57 4 2002 289 304
3. Medical Guidelines for Airline Travel Aviat Space Environ Med 74 5 2003 A1 A19 2nd ed
4. C.C. Christensen, M. Ryg, O.K. Refvem, and O.H. Skjonsberg Development of severe hypoxaemia in chronic obstructive pulmonary disease patients at 2,438 m (8,000 ft) altitude Eur Respir J 15 4 2000 635 639
5. L.M. Seccombe, P.T. Kelly, C.K. Wong, P.G. Rogers, S. Lim, and M.J. Peters Effect of simulated commercial flight on oxygenation in patients with interstitial lung disease and chronic obstructive pulmonary disease Thorax 59 11 2004 966 970
6. A.M. Luks, and E.R. Swenson Travel to high altitude with pre-existing lung disease Eur Respir J 29 4 2007 770 792
7. H. Gong Jr., D.P. Tashkin, E.Y. Lee, and M.S. Simmons Hypoxia-altitude simulation test. Evaluation of patients with chronic airway obstruction Am Rev Respir Dis 130 6 1984 980 986
8. T.A. Dillard, B.W. Berg, K.R. Rajagopal, J.W. Dooley, and W.J. Mehm Hypoxemia during air travel in patients with chronic obstructive pulmonary disease Ann Intern Med 111 5 1989 362 367
9. A.G. Robson, T.K. Hartung, and J.A. Innes Laboratory assessment of fitness to fly in patients with lung disease: a practical approach Eur Respir J 16 2 2000 214 219
10. A. Akero, C.C. Christensen, A. Edvardsen, and O.H. Skjonsberg Hypoxaemia in chronic obstructive pulmonary disease patients during a commercial flight Eur Respir J 25 4 2005 725 730
11. A. Akero, C.C. Christensen, A. Edvardsen, M. Ryg, and O.H. Skjonsberg Pulse oximetry in the preflight evaluation of patients with chronic obstructive pulmonary disease Aviat Space Environ Med 79 5 2008 518 524
12. T.A. Dillard, W.A. Beninati, and B.W. Berg Air travel in patients with chronic obstructive pulmonary disease Arch Intern Med 151 9 1991 1793 1795
13. R.K. Coker, R.J. Shiner, and M.R. Partridge Is air travel safe for those with lung disease? Eur Respir J 30 6 2007 1057 1063
14. T.M. Eagan, T. Ueland, P.D. Wagner, J.A. Hardie, T.E. Mollnes, and J.K. Damas Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study Eur Respir J 35 3 2010 540 548
15. T.M. Eagan, G.E. Eide, A. Gulsvik, and P.S. Bakke Nonresponse in a community cohort study: predictors and consequences for exposure-disease associations J Clin Epidemiol 55 8 2002 775 781
16. D.A. Mahler, and C.K. Wells Evaluation of clinical methods for rating dyspnea Chest 93 3 1988 580 586
17. ATS statement guidelines for the six-minute walk test Am J Respir Crit Care Med 166 1 2002 111 117
18. N. MacIntyre, R.O. Crapo, G. Viegi, D.C. Johnson, C.P. van der Grinten, and V. Brusasco Standardisation of the single-breath determination of carbon monoxide uptake in the lung Eur Respir J 26 4 2005 720 735
19. J. Wanger, J.L. Clausen, A. Coates, O.F. Pedersen, V. Brusasco, and F. Burgos Standardisation of the measurement of lung volumes Eur Respir J 26 3 2005 511 522
20. P.H. Quanjer, G.J. Tammeling, J.E. Cotes, O.F. Pedersen, R. Peslin, and J.C. Yernault Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society Eur Respir J Suppl 16 1993 5 40
21. A. Johannessen, S. Lehmann, E.R. Omenaas, G.E. Eide, P.S. Bakke, and A. Gulsvik Post-bronchodilator spirometry reference values in adults and implications for disease management Am J Respir Crit Care Med 173 12 2006 1316 1325
22. G.A. Borg Psychophysical bases of perceived exertion Med Sci Sports Exerc 14 5 1982 377 381
23. K.F. Rabe, S. Hurd, A. Anzueto, P.J. Barnes, S.A. Buist, and P. Calverley Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary Am J Respir Crit Care Med 176 6 2007 532 555
24. A.O. Johnson Chronic obstructive pulmonary disease (*) 11: fitness to fly with COPD Thorax 58 8 2003 729 732
25. A.S. Buist, M.A. McBurnie, W.M. Vollmer, S. Gillespie, P. Burney, and D.M. Mannino International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study Lancet 370 9589 2007 741 750
26. J.S. Schwartz, H.Z. Bencowitz, and K.M. Moser Air travel hypoxemia with chronic obstructive pulmonary disease Ann Intern Med 100 4 1984 473 477
27. A.G. Robson, and J.A. Innes Problems of air travel for patients with lung disease: clinical criteria and regulations Breathe 3 2 2006 140 147
28. A. Chetta, C. Castagnetti, M. Aiello, F. Sergio, N. Fabiano, and P. Tzani Walking capacity and fitness to fly in patients with chronic respiratory disease Aviat Space Environ Med 78 8 2007 789 792